BCLI
Price
$1.09
Change
-$0.09 (-7.63%)
Updated
Jun 13, 04:59 PM (EDT)
Capitalization
8.73M
VBIZF
Price
$0.24
Change
+$0.02 (+9.09%)
Updated
May 27 closing price
Capitalization
485.41M
Interact to see
Advertisement

BCLI vs VBIZF

Header iconBCLI vs VBIZF Comparison
Open Charts BCLI vs VBIZFBanner chart's image
Brainstorm Cell Therapeutics
Price$1.09
Change-$0.09 (-7.63%)
Volume$805
Capitalization8.73M
Viva Biotech Holdings
Price$0.24
Change+$0.02 (+9.09%)
Volume$546
Capitalization485.41M
BCLI vs VBIZF Comparison Chart
Loading...
BCLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCLI vs. VBIZF commentary
Jun 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCLI is a Hold and VBIZF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 14, 2025
Stock price -- (BCLI: $1.18 vs. VBIZF: $0.24)
Brand notoriety: BCLI and VBIZF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCLI: 13% vs. VBIZF: 15%
Market capitalization -- BCLI: $8.73M vs. VBIZF: $507.12M
BCLI [@Biotechnology] is valued at $8.73M. VBIZF’s [@Biotechnology] market capitalization is $507.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCLI’s FA Score shows that 0 FA rating(s) are green whileVBIZF’s FA Score has 1 green FA rating(s).

  • BCLI’s FA Score: 0 green, 5 red.
  • VBIZF’s FA Score: 1 green, 4 red.
According to our system of comparison, VBIZF is a better buy in the long-term than BCLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCLI’s TA Score shows that 6 TA indicator(s) are bullish.

  • BCLI’s TA Score: 6 bullish, 3 bearish.

Price Growth

BCLI (@Biotechnology) experienced а +4.42% price change this week, while VBIZF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.16%. For the same industry, the average monthly price growth was +20.27%, and the average quarterly price growth was +6.37%.

Reported Earning Dates

BCLI is expected to report earnings on Mar 31, 2025.

Industries' Descriptions

@Biotechnology (+8.16% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VBIZF($485M) has a higher market cap than BCLI($8.73M). VBIZF YTD gains are higher at: 241.326 vs. BCLI (-48.018).
BCLIVBIZFBCLI / VBIZF
Capitalization8.73M485M2%
EBITDA-13.06MN/A-
Gain YTD-48.018241.326-20%
P/E RatioN/A29.01-
Revenue0N/A-
Total Cash168KN/A-
Total Debt841KN/A-
FUNDAMENTALS RATINGS
BCLI: Fundamental Ratings
BCLI
OUTLOOK RATING
1..100
33
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCLI
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 4 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
BCLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HRCPX56.27N/A
N/A
Carillon ClariVest Capital Apprec A
DURCX13.79N/A
N/A
DWS ESG International Core Eq C
PWJQX34.27N/A
N/A
PGIM Jennison International Opps R6
VYSGX14.40N/A
N/A
Voya Small Company W
FQITX13.94N/A
N/A
Fidelity SAI International Qly Idx

VBIZF and

Correlation & Price change

A.I.dvisor indicates that over the last year, VBIZF has been loosely correlated with SMMT. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if VBIZF jumps, then SMMT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VBIZF
1D Price
Change %
VBIZF100%
N/A
SMMT - VBIZF
42%
Loosely correlated
+2.96%
BCLI - VBIZF
35%
Loosely correlated
-4.84%
AKBLF - VBIZF
24%
Poorly correlated
N/A
SPHRY - VBIZF
11%
Poorly correlated
N/A
WXXWY - VBIZF
5%
Poorly correlated
+4.88%
More